HAI

(redirected from Hepatic Arterial Infusion)
AcronymDefinition
HAIHealthcare-Associated Infections
HAIHelicopter Association International
HAIHealing Arts Institute (Fort Collins, CO)
HAIHome Automation, Inc. (New Orleans, LA)
HAIHospital Acquired Infection
HAIHealth Action International
HAIHuman-Animal Interaction
HAIHost Adapter Interface
HAIHardware Accelerator Interface
HAIHemagglutination Inhibition (Immune assay type, microbiology)
HAIHepatic Arterial Infusion (therapy)
HAIHuman Awareness Institute
HAIHealth Alliance International (University of Washington)
HAIHelpAge International (UK)
HAIHellenic Aerospace Industry
HAIHealthcare-Acquired Infection
HAIHuman Appeal International
HAIHotel Association of India
HAIHigh-Current Arc Ignition
HAIHiggenbotham Auctioneers International (Lakeland, FL)
HAIHamamatsu Agency for Innovation (Shizuoka, Japan)
HAIHepatic Activity Index
HAIHockey Art International
HAIHandbook of Artificial Intelligence
HAIHigh Altitude Indoctrination
HAIHigh-Level Analog Input
HAIHigher Authority of Intelligence
References in periodicals archive ?
sup][3] However, chemotherapy (CT) alone or hepatic arterial infusion CT are not favorable for the patients with synchronous CRC and liver metastases (CRCLM); only radical resection of the primary and metastatic lesions can apparently achieve good outcomes.
sup][12],[13] When operation is not a treatment option, alternative therapies, such as local ablation therapies, transarterial chemoembolization, hepatic arterial infusion chemotherapy, or imaging-guided radiation therapy can play a role in patient management.
Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: The end of an era?
Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase II clinical study.
The authors reported the quantitative reverse-transcription polymerase chain reaction (qRT-PCR) analysis of tumour specimens from 94 patients who had advanced CRC and were treated with hepatic arterial infusion of floxuridine and dexamethasone in combination with systemic treatment with irinotecan after resection of liver metastases.
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
The hepatic arterial infusion chemotherapy was initiated after reservoir implantation on an outpatient basis.
Trials evaluating novel biological agents, hepatic arterial infusion chemotherapy and peri-operative chemotherapy suggest further progress is likely.